SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
+35.13%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$428M
AUM Growth
+$428M
(+15%)
Cap. Flow
-$30.5M
Cap. Flow
% of AUM
-7.11%
Top 10 Holdings %
Top 10 Hldgs %
66.43%
Holding
56
New
–
Increased
–
Reduced
6
Closed
1
Top Buys
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$4.45M |
Top Sells
| 1 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$9.98M |
| 2 |
Immunocore
IMCR
|
$3.75M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$3.62M |
| 4 |
HilleVax
HLVX
|
$2.61M |
| 5 |
Recursion Pharmaceuticals
RXRX
|
$2.18M |
Sector Composition
| 1 | Healthcare | 98.11% |
| 2 | Financials | 1.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Astria Therapeutics
ATXS
$394M
| $226K | 0.05% |
25,000
| – | – |
|
|
NGM
52
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $179K | 0.04% |
13,669
| – | – |
|
53
KALA BIO
KALA
$105M
| $132K | 0.03% |
601,162
| – | -$132 |
|
54
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
| $27K | 0.01% |
133,333
| – | – |
|
55
Surrozen, Inc. Warrant
SRZNW
$71.9K
| $18K | ﹤0.01% |
99,999
| – | – |
|
|
56
Recursion Pharmaceuticals
RXRX
$2.02B
| – | – |
-267,996
| Closed | -$2.18M |
|